Skip to main content
. 2021 Dec 17;12:795724. doi: 10.3389/fendo.2021.795724

Table 2.

Follicle growth, clinical pregnancy, and live birth rates in Group OS classified by age at initiation of follow-up.

Age Group
a (<35) b (35–39) c (≥40)
Follicle growth rate 51.6% (81/157) 49.7% (91/183) 39.3% (35/89)
Clinical pregnancy rate 26.8% (42/157)** 12.0% (22/183) 2.2% (2/89)
Live birth rate 21.0% (33/157)** 8.7% (16/183) 1.1% (1/89)
Abortion rate 21.4% (9/42) 27.3% (6/22) 50.0% (1/2)

Group OS, patients who underwent ovarian stimulation by hMG/recFSH with GnRH-a under hormone replacement; Group HR, patients who were observed with estrogen and progestin replacement only.

a, patients <35 years; b, patients 35–39 years; c, patients ≥40 years of age at initiation of follow-up at Rose Ladies Clinic.

**p < 0.01.